
Brian D Radbill, MD
About Me
In the News
Dr. Radbill discusses chronic kidney disease in The Daily News feature The Daily Check Up.
View the PDF.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Nephrology
Education
BA, University of Michigan
MD, Hahnemann University School of Medicine
, Mount Sinai School of Medicine
, Mount Sinai School of Medicine
Research
Previously published data suggests that short daily hemodialysis (2-2.5 hours a day, 6 days a week) may be superior to conventional hemodialysis (3-4 hours a day, 3 days a week) in terms of solute clearance and fluid management. Daily hemodialysis could result in improved dialysis adequacy, improved blood pressure control, decreased cardiac disease (specifically, left ventricular hypertrophy), and decreased mortality. We are working with RRI (Renal Research Institute) as part of a multi-center NIH funded clinical trial studying the potential benefits of short daily hemodialysis versus conventional hemodialysis.
Publications
Selected Publications
- The Impact of Bedside Interdisciplinary Rounds on Length of Stay and Complications. Andrew S. Dunn, Maria Reyna, Brian Radbill, Michael Parides, Claudia Colgan, Tobi Osio, Ari Benson, Nicole Brown, Joy Cambe, Margo Zwerling, Natalia Egorova, Harold Kaplan. Journal of Hospital Medicine
- Data-driven identification of risk factors of patient satisfaction at a large urban academic medical center. Li Li, Nathan J. Lee, Benjamin S. Glicksberg, Brian D. Radbill, Joel T. Dudley. PLoS ONE
- Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: Data from a randomized controlled pilot trial. Lily Li, Marvin Lin, Maria Krassilnikova, Katya Ostrow, Amanda Bader, Brian Radbill, Jaime Uribarri, Joji Tokita, Staci Leisman, Vijay Lapsia, Randy A. Albrecht, Adolfo GarcĂa-Sastre, Andrea D. Branch, Peter S. Heeger, Anita Mehrotra. PLoS ONE